These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 20966810)

  • 1. Superoxide dismutase and nicotinamide adenine dinucleotide phosphate: quinone oxidoreductase polymorphisms and pancreatic cancer risk.
    Mohelnikova-Duchonova B; Marsakova L; Vrana D; Holcatova I; Ryska M; Smerhovsky Z; Slamova A; Schejbalova M; Soucek P
    Pancreas; 2011 Jan; 40(1):72-8. PubMed ID: 20966810
    [TBL] [Abstract][Full Text] [Related]  

  • 2. No associations between Parkinson's disease and polymorphisms of the quinone oxidoreductase (NQO1, NQO2) genes.
    Okada S; Farin FM; Stapleton P; Viernes H; Quigley SD; Powers KM; Smith-Weller T; Franklin GM; Longstreth WT; Swanson PD; Checkoway H
    Neurosci Lett; 2005 Mar; 375(3):178-80. PubMed ID: 15694256
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of superoxide dismutases and NAD(P)H quinone oxidoreductases with prognosis of patients with breast carcinomas.
    Hubackova M; Vaclavikova R; Ehrlichova M; Mrhalova M; Kodet R; Kubackova K; Vrána D; Gut I; Soucek P
    Int J Cancer; 2012 Jan; 130(2):338-48. PubMed ID: 21351093
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oxidative stress in tardive dyskinesia: genetic association study and meta-analysis of NADPH quinine oxidoreductase 1 (NQO1) and Superoxide dismutase 2 (SOD2, MnSOD) genes.
    Zai CC; Tiwari AK; Basile V; de Luca V; Müller DJ; Voineskos AN; Remington G; Meltzer HY; Lieberman JA; Potkin SG; Kennedy JL
    Prog Neuropsychopharmacol Biol Psychiatry; 2010 Feb; 34(1):50-6. PubMed ID: 19778569
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Null association of NQO1 609C>T and NQO2 -3423G>A polymorphisms with susceptibility and prognosis of Esophageal cancer in north Indian population and meta-analysis.
    Umar M; Upadhyay R; Kumar S; Ghoshal UC; Mittal B
    Cancer Epidemiol; 2012 Dec; 36(6):e373-9. PubMed ID: 22770696
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Myeloperoxidase and superoxide dismutase polymorphisms are associated with an increased risk of developing pancreatic adenocarcinoma.
    Wheatley-Price P; Asomaning K; Reid A; Zhai R; Su L; Zhou W; Zhu A; Ryan DP; Christiani DC; Liu G
    Cancer; 2008 Mar; 112(5):1037-42. PubMed ID: 18205184
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic variants in SOD2, MPO, and NQO1, and risk of ovarian cancer.
    Olson SH; Carlson MD; Ostrer H; Harlap S; Stone A; Winters M; Ambrosone CB
    Gynecol Oncol; 2004 Jun; 93(3):615-20. PubMed ID: 15196853
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association analyses between polymorphisms of the phase II detoxification enzymes (GSTM1, NQO1, NQO2) and alcohol withdrawal symptoms.
    Okubo T; Harada S; Higuchi S; Matsushita S
    Alcohol Clin Exp Res; 2003 Aug; 27(8 Suppl):68S-71S. PubMed ID: 12960511
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CYP2A13, ADH1B, and ADH1C gene polymorphisms and pancreatic cancer risk.
    Mohelnikova-Duchonova B; Vrana D; Holcatova I; Ryska M; Smerhovsky Z; Soucek P
    Pancreas; 2010 Mar; 39(2):144-8. PubMed ID: 19812523
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NAD(P)H:quinone oxidoreductase 1 and nrh:quinone oxidoreductase 2 activity and expression in bladder and ovarian cancer and lower NRH:quinone oxidoreductase 2 activity associated with an NQO2 exon 3 single-nucleotide polymorphism.
    Jamieson D; Wilson K; Pridgeon S; Margetts JP; Edmondson RJ; Leung HY; Knox R; Boddy AV
    Clin Cancer Res; 2007 Mar; 13(5):1584-90. PubMed ID: 17332305
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic polymorphisms of MPO, COMT, MnSOD, NQO1, interactions with environmental exposures and bladder cancer risk.
    Hung RJ; Boffetta P; Brennan P; Malaveille C; Gelatti U; Placidi D; Carta A; Hautefeuille A; Porru S
    Carcinogenesis; 2004 Jun; 25(6):973-8. PubMed ID: 14729580
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pesticide exposure on southwestern Taiwanese with MnSOD and NQO1 polymorphisms is associated with increased risk of Parkinson's disease.
    Fong CS; Wu RM; Shieh JC; Chao YT; Fu YP; Kuao CL; Cheng CW
    Clin Chim Acta; 2007 Mar; 378(1-2):136-41. PubMed ID: 17188257
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of NQO1 609C>T and NQO2-3423G>A polymorphisms in susceptibility to gastric cancer in Kashmir valley.
    Malik MA; Zargar SA; Mittal B
    DNA Cell Biol; 2011 May; 30(5):297-303. PubMed ID: 21294640
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Two minor NQO1 and NQO2 alleles predict poor response of breast cancer patients to adjuvant doxorubicin and cyclophosphamide therapy.
    Jamieson D; Cresti N; Bray J; Sludden J; Griffin MJ; Hawsawi NM; Famie E; Mould EV; Verrill MW; May FE; Boddy AV
    Pharmacogenet Genomics; 2011 Dec; 21(12):808-19. PubMed ID: 21946896
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nicotinamide adenine dinucleotide (phosphate) reduced:quinone oxidoreductase and glutathione S-transferase M1 polymorphisms and childhood asthma.
    David GL; Romieu I; Sienra-Monge JJ; Collins WJ; Ramirez-Aguilar M; del Rio-Navarro BE; Reyes-Ruiz NI; Morris RW; Marzec JM; London SJ
    Am J Respir Crit Care Med; 2003 Nov; 168(10):1199-204. PubMed ID: 12969868
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Additive effect between quinine oxidoreductase gene (NQO1: Pro187Ser) and manganese superoxide dismutase gene (MnSOD: Ala-9Val) polymorphisms on tardive dyskinesia in patients with schizophrenia.
    Pae CU
    Psychiatry Res; 2008 Dec; 161(3):336-8. PubMed ID: 18977034
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combined effects of genetic polymorphisms in six selected genes on lung cancer susceptibility.
    Yang M; Choi Y; Hwangbo B; Lee JS
    Lung Cancer; 2007 Aug; 57(2):135-42. PubMed ID: 17428572
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A NAD(P)H:quinone oxidoreductase 1 polymorphism is a risk factor for human colon cancer.
    Begleiter A; Hewitt D; Maksymiuk AW; Ross DA; Bird RP
    Cancer Epidemiol Biomarkers Prev; 2006 Dec; 15(12):2422-6. PubMed ID: 17164365
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased levels of NAD(P)H: quinone oxidoreductase 1 (NQO1) in pancreatic tissues from smokers and pancreatic adenocarcinomas: A potential biomarker of early damage in the pancreas.
    Lyn-Cook BD; Yan-Sanders Y; Moore S; Taylor S; Word B; Hammons GJ
    Cell Biol Toxicol; 2006 Mar; 22(2):73-80. PubMed ID: 16532285
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The NAD(P)H:quinone oxidoreductase 1 gene polymorphism and lung cancer: differential susceptibility based on smoking behavior.
    Xu LL; Wain JC; Miller DP; Thurston SW; Su L; Lynch TJ; Christiani DC
    Cancer Epidemiol Biomarkers Prev; 2001 Apr; 10(4):303-9. PubMed ID: 11319169
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.